About Acenxion Biosytems
Acenxion Biosytems is a private company based in Lawrence, Kansas, incorporated in 2020 in Delaware. It has reported $1,120,000 raised in two offerings on Form D since April 2023. Its chief executive is Roy Swiger.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 19, 2024 | Aug 14, 2024 | $1,070,000fully sold | 5 | $214K | EquityRule 506(b) | Form D ↗ |
| Apr 1, 2023 | Apr 18, 2023 | $50,000of $2.0M target | 1 | $50,000 | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $1,120,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Acenxion Biosytems's Form D filed Aug 14, 2024.
HG
Howard Goldstein
Director
BS
Brian Struchtemeyer
Executive officer and director
RS
Roy Swiger
CEO and director
WC
Wayne Carter
Director